Add to ORKGThis toolkit was produced in the United Kingdom. Who is this toolkit for? The increasing use of NPS within secure environments is presenting prison-based staff with a significant set of new challenges. This toolkit supports custodial, healthcare and substance misuse staff by providing information about the extent of NPS use as we currently understand it and about the properties of the various categories of NPS, and by providing advice on how to manage the problem from a clinical, psychosocial and regime perspective
Summary • All the available official data indicates that in general terms, albeit with some recent ...
The rapid emergence since the mid-2000s of a large and diverse range of substances originally design...
The rapid emergence since the mid-2000s of a large and diverse range of substances originally design...
New Psychoactive Substances (NPS) are a group of drugs that are designed to replicate the effects of...
Background: The use of new psychoactive substances (NPS) in UK prisons is believed to have increased...
The use of new psychoactive substances [NPS] in prisons has been recognised as an increasing problem...
Objectives: Exploring prevalence of new psychoactive substance (NPS) use, and links to impulsivity a...
Background: There has been a significant change in the types of substances consumed within English ...
Background and aims: New Psychoactive Substances (NPS) have affected prison populations, threateni...
Introduction: Novel Psychoactive Substances (NPS), especially Synthetic Cannabinoid Receptor Agonist...
This presentation reports on findings regarding prisoner perceptions on the reasons for violence wit...
The ever-growing number of novel psychoactive substances (NPS) that have been surfacing globally, as...
This chapter explores the everyday experiences of people who use substances in different custodial s...
© 2020 Corazza, Coloccini, Marrinan, Vigar, Watkins, Zene, Negri, Aresti, Darke, Rinaldi, Metastasio...
Endorsed by the Royal Pharmaceutical Society, the guidance is the first of its kind to address this ...
Summary • All the available official data indicates that in general terms, albeit with some recent ...
The rapid emergence since the mid-2000s of a large and diverse range of substances originally design...
The rapid emergence since the mid-2000s of a large and diverse range of substances originally design...
New Psychoactive Substances (NPS) are a group of drugs that are designed to replicate the effects of...
Background: The use of new psychoactive substances (NPS) in UK prisons is believed to have increased...
The use of new psychoactive substances [NPS] in prisons has been recognised as an increasing problem...
Objectives: Exploring prevalence of new psychoactive substance (NPS) use, and links to impulsivity a...
Background: There has been a significant change in the types of substances consumed within English ...
Background and aims: New Psychoactive Substances (NPS) have affected prison populations, threateni...
Introduction: Novel Psychoactive Substances (NPS), especially Synthetic Cannabinoid Receptor Agonist...
This presentation reports on findings regarding prisoner perceptions on the reasons for violence wit...
The ever-growing number of novel psychoactive substances (NPS) that have been surfacing globally, as...
This chapter explores the everyday experiences of people who use substances in different custodial s...
© 2020 Corazza, Coloccini, Marrinan, Vigar, Watkins, Zene, Negri, Aresti, Darke, Rinaldi, Metastasio...
Endorsed by the Royal Pharmaceutical Society, the guidance is the first of its kind to address this ...
Summary • All the available official data indicates that in general terms, albeit with some recent ...
The rapid emergence since the mid-2000s of a large and diverse range of substances originally design...
The rapid emergence since the mid-2000s of a large and diverse range of substances originally design...